Vaxcyte, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PCVX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

389,010

Value ($000)

17,949

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	17,949	0.0%	389,010	12/31/2025
2025 Q3	11/14/2025	14,341	0.0%	398,144	9/30/2025
2025 Q2	8/14/2025	18,043	0.0%	555,008	6/30/2025
2025 Q1	5/19/2025	19,409	0.0%	513,998	3/31/2025
2024 Q4	2/14/2025	38,717	0.0%	472,964	12/31/2024
2024 Q3	11/14/2024	46,653	0.0%	408,274	9/30/2024
2024 Q2	8/14/2024	22,333	0.0%	295,762	6/30/2024
2024 Q1	5/15/2024	7,378	0.0%	108,012	3/31/2024
2023 Q4	2/14/2024	5,117	0.0%	81,473	12/31/2023
2023 Q3	11/13/2023	3,798	0.0%	74,498	9/30/2023
2023 Q2	8/11/2023	2,100	0.0%	56,031	6/30/2023
2023 Q1	5/15/2023	2,100	0.0%	56,031	3/31/2023
2022 Q4	2/14/2023	2,478	0.0%	51,681	12/31/2022
2022 Q3	11/14/2022	831	0.0%	34,628	9/30/2022
2022 Q2	8/12/2022	225	0.0%	10,332	6/30/2022